Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug authorized in the country for addressing Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adults . The medication functions as a https://apolisdexamfetamineincan709653.aioblogs.com/96221036/lisdexamfetamine-in-canada-a-full-explanation